Background: Childhood obesity is associated with premature cardiovascular complications. However, little is known about the effect of a family-based behavioural intervention on the relationship between arterial function, blood pressure and biomarkers in pre-pubertal children with obesity. Design: This was a single centre randomized controlled trial (RCT) including 74 children randomized to a 6-month behavioural intervention to treat obesity. In 48 children (13 controls and 35 interventions), we assessed: serum level of cytokine (CCL2), adiponectin, and neutrophil product (MMP-8), as well as carotid intimamedia thickness, flow-mediated dilation (FMD), nitroglycerin-mediated dilation; arterial stiffness (incremental elastic modulus, Einc), pulse wave velocity (PWV), resting and 24-hour blood pressure (BP). Results: At baseline, resting systolic BP was positively associated with MMP-8 levels which was significantly higher in children with hypertension (P = 0.033). Biochemical markers were not related to endothelial function at baseline, but they globally increased after 6 months in the intervention group. The significant increase of CCL2 levels in the intervention group was associated with a decrease in diastolic BP. Furthermore, adiponectin change was positively related to a change in FMD and negatively to change in Einc and PWV. Conclusions: The usefulness of serum biomarkers for the detection of cardiovascular diseases is not well established in children. In our population, MMP-8
| INTRODUCTION
Cardiovascular diseases are major contributors to the global burden of noncommunicable diseases in the world. Atherosclerosis is a complex multifactorial disease known to start early in life. 1 Childhood obesity is recognized as a risk factor that has been associated with premature cardiovascular complications such as endothelial dysfunction and systemic hypertension.
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One of the major pathophysiological mechanisms of atherosclerosis is the recruitment of circulating leucocytes onto the vessel wall and their subsequent migration into the sub-endothelial space, with activation of inflammation biomarkers. 5 During inflammation or other damage to the vascular wall, neutrophils recruitment is triggered by chemokines (ie, CXCL8), and mediated by interaction with endothelial adhesion molecules. 5, 6 Other noninflammatory mediated mediators, like adipokines, exert an effect on endothelial cells and therefore are interesting in the physiopathology of cardiovascular diseases. 2 More recently, new markers of neutrophil activation have been studied as potential biomarkers of cardiovascular risk and atherogenesis. Among them, myeloperoxidase (MPO), 7 matrix metalloproteinase (MMP-8; MMP-9) 8, 9 and human neutrophil elastase (HNE) 10 are the most promising to detect early vascular changes, as they are directly secreted by activated neutrophils. In addition, MMP-9 has been described as a possible systemic marker of atherosclerotic plaque vulnerability. 11 However, those markers have been poorly studied in children with obesity, especially during a behavioural intervention.
The first aim of this study was to measure these new biochemical markers of neutrophil activation, as well as adipocytokines in pre-pubertal children with obesity, and to assess their relationship with arterial function and systemic blood pressure. Secondly, we aimed to determine the effect of a 6-month family-based behavioural intervention, including supervised physical activity, on these biomarkers in pre-pubertal children with obesity.
| MATERIALS AND METHODS

| Study design and subjects
This study (n = 48 subjects) was nested in a randomized control trial (RCT), which determined the effectiveness of two 6-month interventions combining supervised exercise training and a family-based behavioural intervention (healthy diet, physical activity and well-being) in individual or in group setting, on body mass index, body fatness, cardio-metabolic and psychological co-morbidities in pre-pubertal children with obesity. The full RCT included 74 prepubertal children with obesity aged 7.5-12 years and their mother. Families were randomly distributed in one of the following groups: (a) control (standard care, n = 22); or (b) intervention (n = 52). Sealed opaque envelopes containing 2/3 of intervention and 1/3 of control were used. Families could then choose between an exercise training program twice a week with a behavioural intervention either in an individual setting (7 sessions, one paediatrician and one dietician) or in a group setting (14 sessions, multidisciplinary team).
Subjects were recruited at the Pediatric Obesity Clinic of the University Hospital of Geneva. Obesity was defined as a body mass index (BMI) above the 97th percentile by age and gender. 12 Subjects were excluded from the study if they had any of the following criteria: (a) a pubertal Tanner stage ≥ 2; (b) a history of familial dyslipidemia or hypertension; (c) a history of recent illness, bone fracture or viral syndrome within 2 weeks of the blood draw; (d) taken any medications or hormones which might influence cardiovascular function, body composition, lipid or glucose metabolism in the previous 6 months; (e) a genetic disorder or a chronic disease.
The Mother and Child Ethics Committee of the University Hospitals of Geneva approved this study and a written informed consent was obtained from both parent and child.
For this nested study, we analysed only children with available blood marker data at baseline and at 6 months (48 children: controls, n = 12; group therapy, n = 18; individual therapy, n = 18).
| Measures
All subjects underwent identical testing protocols at the Pediatric Research Platform. The protocol was repeated at 6 months. The health professionals of the Pediatric Research Platform and at the Pediatric Cardiology Unit were blind to group allocation, whereas subjects and intervention delivery staff could not be blinded.
| Anthropometrics and body composition
Standing height was measured to the nearest 0.1 cm on a wall-mounted stadiometer. Weight in kilograms, with light clothes on but shoes off, was measured on scales (Seca). Body mass index (BMI) was calculated as weight/height 2 (kg/m 2 ) and z-scores were derived using the World Health Organization references. 13 Fat mass (FM, kg), fat-free mass (FFM, kg), percentage of total body fat (%) and percentage of abdominal fat (%) were measured using dual-energy Xray absorptiometry (DXA -GE Lunar Prodigy ™ , Lunar
Corp., Madison, WI, USA). 
| Biochemical markers
| Systemic blood pressure
In all subjects, the left brachial resting blood pressure (BP) was assessed by oscillometric method (Dinamap, GE Healthcare, Chicago, IL, USA) after 10 minutes of recumbence. In addition, 24-hour ambulatory BP monitoring (ABPM) was performed at baseline using an automatic monitor with a standing position captor (Dyasis Integra II, Physicor S.A., France) validated by the British Hypertension Society. The BP z-scores were calculated according to the LMS method and HTN was defined as a z-score above 2. 
| Arterial function
Noninvasive measurements of arterial function were performed with a real time B-mode ultrasound imager (Vingmed CFM800C system Ltd, Norway) using a 10 MHz linear high-resolution vascular probe as previously described. 3 Intima-media thickness (IMT) values were categorized according to their percentile, either above or under the 97th percentile for age. 15 The pulse wave of the radial artery was assessed to estimate noninvasively central aortic pressure. This parameter allowed to determine mechanical indices and arterial stiffness using the incremental elastic modulus (Einc). We also assessed the arterial pressure wave at the carotid and femoral arteries to calculate the pulse wave velocity (PWV) according to a standardized method. 16 The PWV and Einc were further categorized according to their percentile, either above or under both the 25th and 75th percentiles for age. 15, 17 Higher Einc and PWV indicated stiffer arteries. Noninvasive assessment of endotheliumdependent dilation (flow-mediated dilation -FMD) and endothelium-independent dilatation (dilatation response to 300 μg sublingual nitroglycerin, NTG) of the right brachial artery (RBA) was performed by the same echographic vascular linear probe. After baseline measure, the dilation of the RBA in response to increased flow or NTG was measured and FMD or NTGMD was calculated as absolute and percentage maximum increase in vessel size from baseline.
| Statistical analysis
Statistical analyses were performed using SPSS software 22.0 (Chicago, IL, USA). For an anticipated effect size of 0.1 for BMI z-score (SD 0.1), a sample size of 16 subjects in each group was required to detect a statistically significant difference at P < 0.05 with a statistical power of 80% (β = 0.80). Due to missing biomarker data, the number of subjects per groups was not sufficient to allow adequate power when assessing intervention changes or comparing groups. Statistical power of intervention changes was 20%-70% for biomarkers, 5%-64% for blood pressure and 6%-39% for endothelial function variables. Power to compare intervention (individual and group together) and control groups was better although still moderate: 45%-70% for endothelial function and 60%-70% for biochemical markers. Despite this limitation, we chose to perform the analyses knowing that our principal aims were to assess the correlations between biochemical markers and other variables. Data were screened initially for normalcy, using skewness and kurtosis tests. Data are presented as mean and standard deviation (SD) or interquartile range for nonnormaly distributed variables (designed with an a in Table 1 ). Since the majority of biomarkers were not normally distributed, we used Spearman's correlations (twotailed) to describe relationships among variables, MannWhitney test to compare groups and Wilcoxon Signed Ranks test to compare variables before and after the intervention. For other normally distributed variables, we used Student's t test, paired t test and chi-square when appropriate. Diagnostic efficiency receiver operating characteristic (ROC) curve was performed with calculation of the area under the curve (AUC) and the determination of a cut-off point for MMP-8 concentration between hypertensive and nonhypertensive children. Differences were considered significant if P < 0.05.
| RESULTS
| Evaluation at baseline
| Patients' characteristics
The characteristics of the 48 children selected for this study are presented in Table 1 .
| Relationship between biochemical markers and blood pressure
Resting systolic and diastolic BP z-scores were positively related to MMP-8 (SBP: r = 0.491, P < 0.001; DBP: r = 0.352, P = 0.019), with significantly higher MMP-8 concentration in children with 24-hour systolic HTN (50.2 ± 42.6 vs 19.6 ± 14.9 ng/mL, P = 0.033; Figure 1A ). The ROC curve ( Figure 1B) showed an AUC of 0.778 (95% CI: 0.582-0.974; P = 0.034) with a cut-off point estimated at 18.3 ng/mL. With this cut-off, the specificity for detecting systolic HTN in children with MMP-8 concentration higher than 18.3 ng/mL was 60% (18/30), the sensitivity 83% (5/6), the positive predictive value 95% (18/19) and the negative predictive value 29% (5/17). Furthermore, CXCL8 was also positively correlated with SBP and DBP z-scores (SBP: r = 0.309, P = 0.041; DBP: r = 0.329, P = 0.029) but did not differ between hypertensive and nonhypertensive children. There was no correlation between any of the markers and 24 hours-BP measures.
| Relationship between biochemical markers and endothelial function
We found no association between marker levels and endothelial function. Furthermore, there was no difference in marker concentrations among children at the different percentiles of Einc, PWV or IMT.
| Evaluation of changes after intervention and correlation with change in adiposity
We investigated the change in biomarker concentrations, blood pressure measurement and endothelial Fat-free mass (kg) 27.5 ± 3.7
Chemokines and adipokines function between baseline and 6 months. As the magnitude of change between individual and group therapies was similar (P > 0.05 for all), we analysed all subjects (n = 35) together in the intervention group. The changes in the control and intervention groups, as well as the effects of the intervention, are presented in Table 2 . A greater BMI z-score decrease was observed in the intervention group compared to controls.
| Biochemical markers
Globally, chemokines and neutrophil products increased in the intervention group and decreased in the control group, but the difference was significant only for MMP-8, MPO and CXCL8 levels. MPO, MMP-9, CCL2 and adiponectin changes were significantly negatively related to change in percentage of abdominal fat (P > 0.05 for all).
| Blood pressure and endothelial function
There was no change in blood pressure measures or vascular function after the intervention. However, in the control group, the significant increase in percentage of abdominal fat was related to a decrease in FMD (r = −0.738, P = 0.037). There was no relationship between change in adiposity and change in blood pressure.
| Correlation between changes in biomarkers and blood pressure
As only eight children performed the 24-hour ambulatory BP monitoring at the two time points, we did not analyse the effect of the intervention on those data. However, at rest, a decrease in resting DBP z-scores was associated with an increase in CCL2 concentrations (r = −0.326, P = 0.035). This association was found in the intervention group only (r = −0.370, P = 0.041).
| Correlation between changes in biomarkers and endothelial function
The increase in CCL-2 concentration was associated with an increase in NTGMD (r = 0.522, P = 0.005) while the decrease in adiponectin level was associated with a decrease in FMD (r = 0.525, P = 0.005, Figure 2A ) as well as an increase in both Einc (r = −0.418, P = 0.030, Figure 2B ) and PWV (r = −0.494, P = 0.009, Figure 2C ).
| DISCUSSION
Our study showed that in pre-pubertal children with obesity, endothelial function parameters were not related to inflammatory biomarkers. However, two of these biomarkers (MMP-8 and CXCL8) correlated with blood pressure at rest, MMP-8 being significantly higher in children with systolic hypertension. A behavioural intervention, including nutrition education and regular physical activity, led not only to an improvement of the BMI z-score but also to an unexpected increase in the levels of these markers. Their increase was shown to be related to a decrease in the percentage of abdominal fat and to an improvement of diastolic blood pressure and endothelial function (NTGMD) for CCL2. Furthermore, changes in adiponectin, a molecule with anti-atherosclerotic properties, were linked to change in endothelial function in children. Obesity is recognized as a risk factor for atherosclerosis through dyslipidemia, hypertension and chronic inflammation. This inflammation leads to the secretion of many biochemical markers known to augment the risk for plaque fissuring and adverse cardiovascular outcomes in adults. 7, 10, 11, [18] [19] [20] [21] In children, CXCL8, MPO, MMP-8
and MMP-9 levels have been shown to be higher in children with obesity compared to children with normal weight, 22-26 MMP-9 being higher in hypertensive than in nonhypertensive children with obesity 23, 27 and MPO correlating with cardiovascular risk factors. 22, 26 In our study, although there was no control group of children with normal weight to compare biomarkers levels, their relationship with cardiovascular health indicators, such as blood pressure and vascular function, was examined.
Resting blood pressure was found to be normal in 85% of children at baseline. However, systolic and diastolic blood pressure z-scores were positively related to MMP-8 and CXCL8 levels. To our knowledge, contrarily to MMP-9, correlations between these biomarkers and blood pressure have never been described in children. In adults, MMP-8 has been recognized as a modulator of angiotensin I cleavage with lower blood pressure in MMP-8 knockout mice. 28 In the present paper, MMP-8 was significantly higher in children with systolic hypertension assessed through 24-hour BP measurement. Based on the difference in MMP-8 levels between children with and without HTN, we proposed a cut-off value with good sensitivity and average specificity. The very high positive predictive value we found (95%) indicates that a value above 18.3 ng/mL suggests HTN, which can be helpful when a 24-hour BP recording cannot be performed. However, this cut-off is valid in pre-pubertal children with obesity only. Furthermore, we explored endothelial function through the evaluation of dependent (FMD) and independent (NTGMD) dilatation of the carotid artery, which reflects the early stage of alteration in vasomotor activity as well as arterial stiffness (Einc and PWV) and IMT. Despite the lack of control group at baseline, it is reasonable to assume, given our findings in a previous publication on a subjects in the present study had impaired endothelial function. Despite this, we did not find any relationship between measured markers and vascular function, or any difference in markers concentration through vascular measures percentiles. This may suggest that those markers are not appropriate to detect early vascular changes or that their variability is too high to be able to detect such subtle changes. One pediatric study performed in older subjects with obesity showed that MMP-9 levels and IMT of the carotid arteries were higher compared to a control group and that they were correlated to each other. 25 To our knowledge, no other study has investigated the relationship between biomarkers and vascular function, especially in pre-pubertal children with obesity. In addition, the effect of behavioural interventions on these inflammatory biochemical markers has never been studied in children. In our sample, despite an improvement of BMI z-score, children in the intervention group showed unexpected proportional increase in inflammatory markers (CCL2, CXCL8) and proteases (MPO, MMP-8) when compared with the control group. Indeed, almost all the markers (except one: CCL-2) did decrease in the control group, with all of them increasing in the intervention group. These different trends highlight a controversial effect of the intervention on those markers. We might speculate on different reasons why these markers decreased only in the control group. First of all, the control group was treated with a "standard treatment care" that could have induced some modifications and partial improvement on the levels of inflammatory biomarkers. These data are rather observational since, differently from adult with obesity, these modifications have not been clearly associated with clinical outcomes in children. On the other hand, the observed increase in the intervention group could be explained by a paradoxical effect of lifestyle change on inflammation. One Mean change is defined as the variable change from baseline to 6 mo in each groups and is indicated as mean and SD. CCL2, chemokine ligand 2; CXCL8, interleukin 8; DBP, diastolic blood pressure; Einc, elastic incremental modulus; FMD, flow-mediated dilation; HNE, Neutrophil Elastase; IMT, intima-media thickness; MMP-8 and 9, matrix metalloprotease; MPO, myeloperoxidase; NTGMD, nitroglycerin-mediated dilation; PWV, aortic pulse wave velocity; SBP, systolic blood pressure. *P < 0.05; * * P < 0.01 for intra-group change. component of the intervention was the introduction of regular physical activity twice a week for a total amount of 3 hours per week. This factor, even though not alone, may have had an effect on those markers. Indeed, a study performed in adults with artheriopathy showed that a shortterm exercise (treadmill test) induced an activation of tissue metalloproteinases and an increased expression of adhesion molecules and inflammatory substances. 29 These results may suggest that regular physical activity during a short period of time could have negative effects on cardio-metabolic parameters. However, the clinical implication of this increase is difficult to ascertain, especially in pre-pubertal children without known artheriopathy. To our knowledge, no studies have investigated the effect of a long-term period of physical activity in human. However, in rats, a 2-week program of physical activity, which may be representative of a long-term period for human, induced some damage to skeletal muscles and connective tissue, which lead to activation of tissue metalloproteinases. 30 In our study, we looked at the clinical impact of the intervention, which included healthy lifestyle changes as well as physical activity, on cardiovascular health indicators such as blood pressure or vascular function, and their relationship with biomarkers changes. We could demonstrate that increases in CCL2 levels were related to an improvement in diastolic blood pressure and smooth muscle cell function (increase in NTGMD) in the intervention group. Therefore, these markers may have a long-term beneficial effect, and caution is required in the interpretation of this increase, especially in the light of the complex and unclear roles of these markers and their regulators. 31 The direct effect of physical activity could not be evaluated in our study first because we did not monitor the total amount of physical activity performed by children and also because of other potential metabolic changes induced by the various lifestyle changes that occurred during the intervention. Indeed it is known that there is a multitude of hormonal and biochemical factors that are implicated in vascular control, inflammation and weight regulation, which may have been influenced by lifestyle changes.
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The behavioural intervention did not have a significant effect on the endothelial function, probably due to the small number of subjects. However, a decrease in adiponectin level was related to a worsening of the endothelial function (decreased FMD), as well as an increase in Einc and PWV. Adiponectin is an adipocyte-derived protein known to suppress the attachment of monocytes to endothelial cells and lipid accumulation in macrophage and is consequently considered as an anti-atherogenic protein. 34 Thus, our findings seem to confirm its protective role on vascular walls. 35, 36 It is worth noting that one study performed in children showed no relationship between adiponectin and FMD, 37 however their adiponectin level may have been too high to reveal an association with impaired endothelial function. The latter study also corroborates our finding that adiponectin is not yet related to IMT in young children, contrarily to results found in adolescent studies. 38, 39 Furthermore, in our control group, the percentage of abdominal fat mass increased after 6 months with a deleterious effect on vascular function (decreased FMD). This study has some limitations. First, the sample size was probably too low to observe significant changes between the two groups and the impact of the intervention. Second, only few children consented to do the 24 hoursambulatory BP test at the end of the trial.
In conclusion, our results suggested that among the new biomarkers, only MMP-8 may be used to detect high blood pressure in pre-pubertal children with obesity. Furthermore, a "short-term" exercise training program, combined with a family-based behavioural intervention, may increase low-grade inflammation with the secretion of neutrophil products, with an unexpected beneficial impact on blood pressure and endothelial function, especially for CCL2. Furthermore, the beneficial effect of lifestyle interventions on adiposity may prevent the decrease in adiponectin concentration and consequently preserve arterial wall properties. Numerous adult studies have demonstrated the beneficial long-term effect of regular physical activity on vascular health. Further pediatric studies are now needed to investigate the effect of interventions of different types, durations, frequencies and intensities on the secretion of vascular biomarkers and changes of vascular function.
